ABCA7 |
No |
|
No |
|
No |
|
Involved in lipid homeostasis; enhances Aβ clearance by macrophages (40, 41) |
APOE |
Yes |
(42–44) |
Maybe |
(45) |
Maybe |
(46) |
Involved in lipid metabolism (42–44) |
CD33 |
Yes |
(47) |
Maybe |
(48) |
Maybe |
(49) |
Inhibitory receptor exclusive to immune cells (47) |
CLU |
No |
|
No |
|
Yes |
(50) |
Inhibitor of complement receptors (50) |
CR1 |
Yes |
(51) |
Yes |
(52) |
Yes |
(53) |
Influences complement cascade; binds C1q; inhibits formation of MAC (52, 54) |
EPHA1 |
No |
|
No |
|
No |
|
Promotes permeability of the blood-brain barrier (55, 56) |
HLA-DRB1 |
No |
|
No |
|
No |
|
Creates beta chain 1 of the MHC class II protein complex |
HLA-DRB5 |
No |
|
No |
|
No |
|
Creates beta chain 5 of the MHC class II protein complex |
INPP5D |
Yes |
(57, 58) |
No |
|
No |
|
Binds DAP12 which inactivates the TREM2-DAP12 signaling complex (59) |
MEF2C |
Maybe |
(60) |
No |
|
No |
|
Regulates apoptosis of T cells and is necessary for transcriptional activation of IL-2 (61, 62) |
MS4A cluster (MS4A4E and MS4A6A) |
Maybe |
(63) |
No |
|
Maybe |
(63) |
Ligand binding promotes calcium conductance; may modulate TREM2 expression (and TLR/complement through TREM2) (63) |
TLR4 variant (rs4986790) |
Yes |
|
Yes |
|
No |
|
Altered ability to recruit MyD88 and TRIF (64) |
TREM2 |
Yes |
(65, 66) |
Maybe |
(67) |
Yes |
(68, 69) |
Found on myeloid cells and alters inflammatory functions (70) |